Authors
Michael Nordness, Sharmilee M Nyenhuis, Nicholas L Rider, Stanley J Szefler, Sujani Kakumanu
Published in
The journal of allergy and clinical immunology. In practice. Volume 14. Issue 10. Pages 2189-2197.e1.
Abstract
The integration of research discoveries into routine clinical care is often slow and resource-intensive, particularly in allergy and immunology, where advances in biologics, immunotherapy, precision diagnostics, and guideline-driven management continue to evolve rapidly. Implementation science provides a structured approach to understand and address the gaps between research discovery and real-world patient care. In asthma, food allergy, atopic dermatitis, drug allergy, and primary immune disorders, variation in clinician knowledge, health system infrastructure, reimbursement models, patient demographics, and staffing patterns contribute to inconsistent uptake of evidence-based interventions. Implementation science offers tools to systematically evaluate these contextual factors and develop strategies that improve adoption, fidelity, sustainability, and equity in allergic and immunologic care. By offering theory-informed frameworks to design, adapt, and evaluate interventions across diverse clinical settings, implementation science advances the study of evidence-to-practice care gaps in allergy and immunology. When applied thoughtfully, these methods enhance implementation of specialty guidelines, practice parameters, and emerging therapies, while addressing multilevel determinants of care delivery. With the rapidly growing application of precision medicine and augmented intelligence to allergy and immunology practice, the study of how to best apply technological and research discovery to clinical practice will be needed to promote equitable uptake of evidence-based care.
PMID:
42843931
Bibliographic data and abstract were imported from PubMed on 08 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 3
- Comments 0